Published in J Viral Hepat on April 01, 2008
Differences in clinical outcomes among hepatitis C genotype 1-infected patients treated with peginterferon alpha-2a or peginterferon alpha-2b plus ribavirin: a meta-analysis. Clin Exp Gastroenterol (2012) 0.93
Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study. BMC Pharmacol (2010) 0.83
Meta-analysis: mortality and serious adverse events of peginterferon plus ribavirin therapy for chronic hepatitis C. J Gastroenterol (2012) 0.79
Estimates of HCV-1 patients attaining RVR following dual therapy with peg-interferon and ribavirin. Dig Dis Sci (2012) 0.75
Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol (2000) 2.94
Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology (2005) 1.68
Determination of waterborne 222Rn concentrations using AC canisters. Health Phys (1995) 1.38
Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion. Lab Invest (2001) 1.33
Biological and clinical relevance of Laminin-5 in cancer. Clin Exp Metastasis (2000) 1.11
New frontiers in biomarkers for hepatocellular carcinoma. Dig Liver Dis (2006) 1.05
Spontaneous and Fas-induced apoptotic cell death in aged neutrophils. J Clin Immunol (1998) 1.05
Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford) (2007) 1.05
Lung metastases from differentiated thyroid carcinoma. A 40 years' experience. Q J Nucl Med Mol Imaging (2004) 1.05
Prospective comparative evaluation of quantitative-elastosonography (Q-elastography) and contrast-enhanced ultrasound for the evaluation of thyroid nodules: preliminary experience. Eur J Radiol (2013) 1.00
Tissue remodelling in liver diseases. Histol Histopathol (2003) 0.98
MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis. Clin Exp Rheumatol (2004) 0.97
Changes in expression of monoclonal antibody epitopes on laminin-5r induced by cell contact. J Cell Sci (1996) 0.95
In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C. Eur J Gastroenterol Hepatol (1997) 0.95
Matrix metalloproteinase imbalance in muscle disuse atrophy. Histol Histopathol (2005) 0.94
Role of lipopolysaccharide and related cytokines in Helicobacter pylori infection. Recenti Prog Med (1997) 0.94
Single brain metastasis from thyroid cancer: report of twelve cases and review of the literature. J Neurooncol (2001) 0.94
Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer. Anticancer Res (2010) 0.94
Rat hindlimb unloading by tail suspension reduces osteoblast differentiation, induces IL-6 secretion, and increases bone resorption in ex vivo cultures. Calcif Tissue Int (2002) 0.94
Perihepatic lymphadenopathy and the response to therapy in chronic hepatitis C patients(). J Ultrasound (2010) 0.93
Soluble (s) CD14 and plasmatic lipopolysaccharides (LPS) in patients with chronic hepatitis C before and after treatment with interferon (IFN)-alpha. Immunopharmacol Immunotoxicol (1998) 0.93
Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha. J Clin Immunol (2000) 0.91
MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Anticancer Res (2007) 0.91
Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma. Cytokine (2000) 0.89
Gelatinases and their inhibitors in tumor metastasis: from biological research to medical applications. Histol Histopathol (2002) 0.88
Age-associated changes of neutrophil responsiveness in a human healthy elderly population. Cytobios (1994) 0.87
A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection. J Interferon Cytokine Res (1999) 0.86
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapy. Clin Exp Immunol (1996) 0.85
Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cells. Br J Cancer (2004) 0.85
Immunogenic properties of a chimeric plant virus expressing a hepatitis C virus (HCV)-derived epitope: new prospects for an HCV vaccine. J Clin Immunol (2005) 0.84
Cucumber mosaic virus as a presentation system for a double hepatitis C virus-derived epitope. Arch Virol (2007) 0.83
Immunological and molecular aspects of liver fibrosis in chronic hepatitis C virus infection. Histol Histopathol (2005) 0.83
sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology. Immunopharmacol Immunotoxicol (2000) 0.83
HGF and M-CSF modulate adhesion of MDA-231 breast cancer cell by increasing osteopontin secretion. J Biol Regul Homeost Agents (2002) 0.83
Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. J Exp Clin Cancer Res (1999) 0.82
Immunoregulation in aging. Diagn Clin Immunol (1987) 0.82
Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto's thyroiditis. Eur Surg Res (2010) 0.81
Cell-mediated immune response in psoriasis and psoriatic arthritis. Recenti Prog Med (1989) 0.81
Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma. Curr Pharm Des (2007) 0.81
Surgical technique and biomaterials for totally implanted port catheter systems. J Chemother (1997) 0.81
Two-dimensional immunolectrophoresis as a diagnostic tool for heavy chain disease. Boll Ist Sieroter Milan (1975) 0.81
Characterization of morphological and cytoskeletal changes in MCF10A breast epithelial cells plated on laminin-5: comparison with breast cancer cell line MCF7. Cell Commun Adhes (2001) 0.81
Non-specific immunity in aging: deficiency of monocyte and polymorphonuclear cell-mediated functions. Mech Ageing Dev (1984) 0.81
In vitro vitamin E and selenium supplementation improves neutrophil-mediated functions and monocyte chemoattractant protein-1 production in the elderly. Cytobios (1994) 0.81
Liver tissue expression of CD80 and CD95 antigens in chronic hepatitis C: relationship with biological and histological disease activities. Microbios (1999) 0.81
Fine needle aspiration biopsy in the preoperative management of patients with thyroid nodules. Anticancer Res (1999) 0.81
Cucumber mosaic virus as the expression system for a potential vaccine against Alzheimer's disease. J Virol Methods (2010) 0.81
Relationship between respiratory burst and adhesiveness capacity in elderly polymorphonuclear cells. Mech Ageing Dev (1993) 0.80
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients. J Viral Hepat (2012) 0.80
Cucumber mosaic virus as carrier of a hepatitis C virus-derived epitope. Arch Virol (2003) 0.80
Clinical outcomes of bosentan in pulmonary arterial hypertension do not correlate with levels of TIMPs. Eur J Clin Invest (2006) 0.79
Phenotypic immaturity of T and B lymphocytes in cord blood of full-term normal neonates. Analysis of cell surface markers by using conventional techniques and monoclonal antibodies. Biol Neonate (1983) 0.79
Interleukin-12 p40/p70 ratio and in vivo responsiveness to IFN-alpha treatment in chronic hepatitis C. J Interferon Cytokine Res (2001) 0.79
HIV-infection and in vivo lipopolysaccharide-induced release of cytokines. An amplified mechanism of damage to the host. Acta Neurol (Napoli) (1991) 0.79
Effects of interferon-alpha treatment on neutrophil oxidative metabolism, lymphocyte proliferation and monocyte HLA class I antigen expression in patients with chronic hepatitis C. Immunopharmacol Immunotoxicol (1996) 0.79
CD45RA and CD45RO isoform expression on intrahepatic T-lymphocytes in chronic hepatitis C. Microbios (1997) 0.79
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients. Med Microbiol Immunol (2008) 0.79
Relationship between immune system and gram-negative bacteria. II. Natural killer cytotoxicity of Salmonella minnesota Rb 345-unbound human peripheral blood lymphocytes. J Immunol (1984) 0.79
Enhancement of polymorphonuclear cell phagocytosis by lipid A-activated monocytes via cell-to-cell contact. A possible role for membrane-associated cytokines. Immunopharmacol Immunotoxicol (1992) 0.79
[Autoimmune hemolytic anemia in chronic hepatitis C virus infection treated with alpha-interferon: a therapy-related event or extra-hepatic immunologic manifestation?]. Recenti Prog Med (1999) 0.79
Relationship between immune system and gram negative bacteria. I. Spontaneous binding of smooth and rough Salmonella to human peripheral blood lymphocytes. Clin Exp Immunol (1984) 0.79
Endometriosis is characterized by an impaired localization of laminin-5 and alpha3beta1 integrin receptor. Int J Gynecol Cancer (2007) 0.79
Analysis of mononuclear cell subsets in pregnancies with intrauterine growth retardation. Evidence of chronic B-lymphocyte activation. J Perinat Med (1983) 0.78
Lipoprotein-induced inhibition of plaque-forming cell generation and natural killer cell frequency in aged donors. Ann Immunol (Paris) (1984) 0.78
Helicobacter pylori infection and host cell responses. Immunopharmacol Immunotoxicol (1999) 0.78
Rationale for new drugs targeting the tissue microenvironment in patients with HCC. Curr Pharm Des (2007) 0.78
Thymostimulin administration modulates polymorph metabolic pathway in patients with chronic obstructive pulmonary disease. Immunopharmacol Immunotoxicol (1992) 0.78
In vitro modulation of cell-mediated immunity by prostaglandin E2. I. Enhancing-inhibitory effects on antibody-dependent cellular cytotoxicity. Prostaglandins Leukot Med (1982) 0.78
Humoral immune response in aged humans: suppressor effect of monocytes on spontaneous plaque forming cell generation. Clin Exp Immunol (1983) 0.78
Phagocytosis of Leishmania infantum promastigotes by monocytes isolated from Leishmania-infected dogs. Microbiologica (1986) 0.78
In vitro modulation of cell-mediated immunity by prostaglandin E2. II. Enhancement of spontaneous plaque-forming cell generation. Prostaglandins Leukot Med (1982) 0.78
Natural and antibody-dependent cellular cytotoxicity in patients with active sarcoidosis. Allergol Immunopathol (Madr) (1983) 0.78
Interferon alpha modulates an inverse relationship between mitogenesis and antibody synthesis on human peripheral blood lymphocytes (PBL) Cell Immunol (1982) 0.78
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-α. Clin Microbiol Infect (2011) 0.78
[Case report of a multiple complex odontoma]. Zahnarztl Prax (1985) 0.78
Polymorphonuclear cell-mediated phagocytosis and superoxide anion release in insulin-dependent diabetes mellitus. Cytobios (1993) 0.77
Vitiligo, autoimmune thyroiditis: a rare thyroid cancer arising with bone metastates on maxillofacial area. J Exp Clin Cancer Res (1999) 0.77
Altered expression of integrins and basement membrane proteins in malignant and pre-malignant lesions of oral mucosa. J Biol Regul Homeost Agents (2002) 0.77
Regulatory role of extracellular matrix proteins in neutrophil respiratory burst during aging. Mech Ageing Dev (2000) 0.77
Age-related impairment of T cell proliferative responses related to the decline of CD28+ T cell subsets. Arch Gerontol Geriatr (2008) 0.77
Abnormal T-cell functions in B-cell chronic lymphocytic leukemia do not imply T-lymphocyte involvement in the leukemic process: report of a case with demonstrated "polyclonality" of T lymphocytes. J Clin Immunol (1983) 0.77
In vitro effects of recombinant human granulocyte-macrophage colony-stimulating factor (RhGM-CSF) on polymorphonuclear cell (PMN) and monocyte (MO) functional capacities in ovarian cancer patients versus human volunteers. Immunopharmacol Immunotoxicol (1997) 0.77
Hepatitis C virus infection: immune responsiveness and interferon-alpha treatment. Curr Pharm Des (2000) 0.77
[Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?]. Recenti Prog Med (2001) 0.77
In vitro effects of human lipoproteins on the immune system in healthy donors: inhibition of plaque forming cell generation and decreased frequency of NK cells. Clin Exp Immunol (1984) 0.77
Neutrophil apoptotic cell death: does it contribute to the increased infectious risk in aging? Microbios (2001) 0.77
In vitro production of tumor necrosis factor-alpha, interleukin-6 and interleukin-8 from normal human peripheral blood mononuclear cells stimulated by Rhodococcus equi. Vet Microbiol (1997) 0.77
Mononuclear cell subpopulations during normal pregnancy: I. Analysis of cell surface markers using conventional techniques and monoclonal antibodies. Am J Reprod Immunol (1984) 0.77
Cryoimmunoglobulinemia in four sisters. Acta Haematol (1978) 0.77
Percoll density gradient centrifugation. (An improved method for the enrichment of lymphocyte subsets mediating different activities). Ric Clin Lab (1982) 0.77
Apoptotic effects of a chimeric plant virus carrying a mimotope of the hepatitis C virus hypervariable region 1: role of caspases and endoplasmic reticulum-stress. J Clin Immunol (2012) 0.76
Treatment with natural IFN of hepatitis C patients with or without antibodies to recombinant IFN. Hepatogastroenterology (1995) 0.76
Immunological responses in patients with tuberculosis and in vivo effects of acetyl-L-carnitine oral administration. Mediators Inflamm (1993) 0.76
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. J Viral Hepat (2012) 0.76
Squamous cellular carcinoma immunocomplexed is increased in scleroderma patients with lung fibrosis. Clin Exp Rheumatol (2007) 0.76
Pilot study of intravenous administration of the acid-treated Salmonella minnesota R595 (Re) in cancer patients. Tumori (1987) 0.76